Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q1)Jun 30, 2025 | (FY)Mar 31, 2025 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 4.34%316.05B | 3.14%1.19T | 3.20%302.91B | 4.33%1.15T | 5.07%268.92B | 2.16%299.62B | 4.04%289.9B | 6.25%293.52B | 5.59%1.1T | 5.06%255.96B |
| Cost of revenue | 4.20%292.36B | 3.14%1.1T | 3.22%280.56B | 4.29%1.07T | 5.24%248.95B | 1.93%276.57B | 3.81%268.27B | 6.41%271.82B | 5.99%1.02T | 5.48%236.56B |
| Gross profit | 5.98%23.69B | 3.04%88.98B | 2.98%22.35B | 4.81%86.36B | 3.00%19.98B | 4.93%23.05B | 6.89%21.63B | 4.34%21.7B | 0.78%82.4B | 0.15%19.39B |
| Operating expense | 7.65%16.06B | 3.02%60.97B | 1.29%14.92B | 2.18%59.19B | 5.26%14.77B | 0.24%14.85B | 0.29%14.83B | 3.12%14.73B | 3.73%57.92B | 2.61%14.03B |
| Selling and administrative expenses | 7.65%16.06B | 3.02%60.97B | 1.29%14.92B | 2.18%59.19B | 5.26%14.77B | 0.24%14.85B | 0.29%14.83B | 3.12%14.73B | 3.73%57.92B | 2.61%14.03B |
| -General and administrative expense | 7.65%16.06B | 3.02%60.97B | 1.29%14.92B | 2.18%59.19B | 5.26%14.77B | 0.24%14.85B | 0.29%14.83B | 3.12%14.73B | 3.73%57.92B | 2.61%14.03B |
| Operating profit | 2.62%7.62B | 3.08%28.01B | 6.55%7.43B | 11.04%27.17B | -2.91%5.21B | 14.64%8.2B | 24.83%6.8B | 7.03%6.97B | -5.59%24.47B | -5.75%5.36B |
| Net non-operating interest income (expenses) | 0.00%-1M | -20.00%-6M | 0.00%-1M | 0.00%-5M | 0.00%-1M | 0.00%-2M | 0.00%-1M | 0.00%-1M | 16.67%-5M | 50.00%-1M |
| Non-operating interest expense | 0.00%1M | 20.00%6M | 0.00%1M | 0.00%5M | 0.00%1M | 0.00%2M | 0.00%1M | 0.00%1M | -16.67%5M | -50.00%1M |
| Net investment income | 1.68%182M | 14.92%516M | 16.23%179M | 16.93%449M | 6.58%81M | 12.00%112M | 34.21%102M | 16.67%154M | 1.59%384M | 8.57%76M |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | 0 | 621.43%1.01B | 232.86%466M | 836.84%140M | 0 | 0 | 0 | 140M | -272.73%-19M | -733.33%-19M |
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | 477M | 99.53%-6M | 0 | -401.88%-1.29B | -363.99%-1.28B | 0 | -200.00%-3M | 0 | 265.12%426M | 172.32%486M |
| Less:Other special charges | ---477M | -94.67%13M | ---- | 158.51%244M | 150.52%241M | --0 | ---- | ---- | -189.58%-417M | -372.57%-477M |
| Less:Write off | ---- | -100.67%-7M | ---- | 11,677.78%1.04B | ---- | ---- | ---- | ---- | -102.24%-9M | ---- |
| Other non-operating income (expenses) | 2.29%715M | 8.09%3.17B | -1.96%699M | 13.18%2.93B | 2.21%602M | 6.20%737M | 42.60%877M | 3.33%713M | 10.36%2.59B | 8.47%589M |
| Income before tax | 2.55%9B | 11.20%32.69B | 9.92%8.77B | 5.57%29.4B | -29.17%4.6B | 14.43%9.05B | 26.67%7.77B | 9.12%7.98B | -1.92%27.85B | 15.35%6.49B |
| Income tax | 2.23%2.76B | 12.17%9.82B | 9.86%2.7B | 1.91%8.76B | -44.59%1.11B | 14.33%2.79B | 26.46%2.4B | 8.97%2.45B | -1.78%8.59B | 15.76%2B |
| Net income | 2.70%6.24B | 10.79%22.86B | 9.97%6.08B | 7.20%20.64B | -22.27%3.49B | 14.44%6.25B | 26.79%5.37B | 9.19%5.53B | -1.98%19.25B | 15.14%4.5B |
| Net income continuous operations | 2.70%6.24B | 10.79%22.87B | 9.95%6.08B | 7.20%20.64B | -22.31%3.49B | 14.48%6.25B | 26.77%5.37B | 9.19%5.53B | -1.98%19.25B | 15.16%4.5B |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | 2.70%6.24B | 10.79%22.86B | 9.97%6.08B | 7.20%20.64B | -22.27%3.49B | 14.44%6.25B | 26.79%5.37B | 9.19%5.53B | -1.98%19.25B | 15.14%4.5B |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 2.70%6.24B | 10.79%22.86B | 9.97%6.08B | 7.20%20.64B | -22.27%3.49B | 14.44%6.25B | 26.79%5.37B | 9.19%5.53B | -1.98%19.25B | 15.14%4.5B |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 4.65%101.18 | 11.59%366.46 | 9.96%96.68 | 7.20%328.4 | -22.27%55.6 | 14.44%99.48 | 26.82%85.4 | 9.18%87.92 | -1.29%306.33 | 14.91%71.53 |
| Diluted earnings per share | 4.65%101.18 | 11.59%366.46 | 9.96%96.68 | 7.20%328.4 | -22.27%55.5956 | 14.44%99.48 | 26.82%85.3982 | 9.18%87.92 | -1.29%306.33 | 15.14%71.5231 |
| Dividend per share | 0 | 11.70%105 | 0 | 14.63%94 | 19.51%49 | 0 | 9.76%45 | 0 | 5.13%82 | 5.13%41 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |